Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11290802rdf:typepubmed:Citationlld:pubmed
pubmed-article:11290802lifeskim:mentionsumls-concept:C0002092lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C0458827lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C0253486lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C0805586lld:lifeskim
pubmed-article:11290802lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:11290802pubmed:issue8lld:pubmed
pubmed-article:11290802pubmed:dateCreated2001-4-6lld:pubmed
pubmed-article:11290802pubmed:abstractTextTo evaluate the role of CCR2 in allergic asthma, mutant mice deficient in CCR2 (CCR2(-/-)) and intact mice were sensitized with i.p. OVA with alum on days 0 and 7, and challenged by inhalation with nebulization of either OVA or saline. Airway hyperreactivity, measured by the methacholine-provoked increase in enhanced pause, was significantly increased (p < 0.05) in OVA-challenged CCR2(-/-) mutant mice, compared with comparably challenged CCR2(+/+) mice. OVA-challenged CCR2(-/-) mutants also were also found to have enhanced bronchoalveolar lavage fluid eosinophilia, peribronchiolar cellular cuffing, and Ig subclass switching, with increase in OVA-specific IgG(1) and IgE. In addition, RNase protection assay revealed increased whole lung expression of IL-13 in OVA-challenged CCR2(-/-) mutants. Unexpectedly, serum monocyte chemotactic protein-1 levels were 8-fold higher in CCR2(-/-) mutants than in CCR2(+/+) mice sensitized to OVA, but OVA challenge had no additional effect on circulating monocyte chemotactic protein-1 in either genotype. Ag stimulation of lymphocytes isolated from OVA-sensitized CCR2 mutants revealed a significant increase (p < 0.05) in IL-5 production, which differed from OVA-stimulated lymphocytes from sensitized CCR2(+/+) mice. These experiments demonstrate an enhanced response in airway reactivity and in lung inflammation in CCR2(-/-) mutant mice compared with comparably sensitized and challenged CCR2(+/+) mice. These observations suggest that CC chemokines and their receptors are involved in immunomodulation of atopic asthma.lld:pubmed
pubmed-article:11290802pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:languageenglld:pubmed
pubmed-article:11290802pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11290802pubmed:statusMEDLINElld:pubmed
pubmed-article:11290802pubmed:monthAprlld:pubmed
pubmed-article:11290802pubmed:issn0022-1767lld:pubmed
pubmed-article:11290802pubmed:authorpubmed-author:KimYYlld:pubmed
pubmed-article:11290802pubmed:authorpubmed-author:FeldmanSSlld:pubmed
pubmed-article:11290802pubmed:authorpubmed-author:FuS MSMlld:pubmed
pubmed-article:11290802pubmed:authorpubmed-author:SaksR GRGlld:pubmed
pubmed-article:11290802pubmed:authorpubmed-author:KuzielW AWAlld:pubmed
pubmed-article:11290802pubmed:authorpubmed-author:Sung Sslld:pubmed
pubmed-article:11290802pubmed:issnTypePrintlld:pubmed
pubmed-article:11290802pubmed:day15lld:pubmed
pubmed-article:11290802pubmed:volume166lld:pubmed
pubmed-article:11290802pubmed:ownerNLMlld:pubmed
pubmed-article:11290802pubmed:authorsCompleteYlld:pubmed
pubmed-article:11290802pubmed:pagination5183-92lld:pubmed
pubmed-article:11290802pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:meshHeadingpubmed-meshheading:11290802...lld:pubmed
pubmed-article:11290802pubmed:year2001lld:pubmed
pubmed-article:11290802pubmed:articleTitleEnhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2).lld:pubmed
pubmed-article:11290802pubmed:affiliationDivision of Pulmonary and Critical Care Medicine, and Division of Rheumatology and Immunology, University of Virginia Health System, Charlottesville, VA 22908, USA.lld:pubmed
pubmed-article:11290802pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11290802pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11290802pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12772entrezgene:pubmedpubmed-article:11290802lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11290802lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11290802lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11290802lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11290802lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11290802lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11290802lld:pubmed